This author has not written his bio yet.
But we are proud to say that MBCA contributed 46 entries already.
A study showed that people with HR-positive, HER2-negative metastatic breast cancer who took an oral drug known as a CDK4/6 inhibitor combined with hormone therapy fared better than people who […]
The FDA has approved a new oral drug for the treatment of HR-positive, HER2-negative advanced breast cancer. A companion blood test was also approved to help doctors identify patients who […]
Innovative drug offers a novel option for those living with ER+, HER2- metastatic breast cancer The U.S. Food and Drug Administration has just approved its first new hormone therapy in […]
The study TROPiCS-2 showed that the drug Trodelvy (sacituzumab govitecan) improved progression-free survival when compared to chemotherapy in people with advanced metastatic ER/PR-positive, HER2-negative breast cancer who have few other […]
More progress needs to be made to improve outcomes for Black women with breast cancer. Here’s how BCRF investigators are addressing the challenge. In the United States, breast cancer continues […]
Metastatic Breast Cancer Alliance
28 West 44th Street
Suite 609
New York, NY 10036